Wannemacher & Partner Rechtsanwälte
20.11.2024 20:54:07 CET | Globenewswire | Press release
Wannemacher & Partner Rechtsanwälte Confirms Termination of Money Laundering Investigation Against Alisher Usmanov in Germany
Wannemacher & Partner Rechtsanwälte Confirms Termination of Money Laundering Investigation Against Alisher Usmanov in Germany
German investigators waive prosecution against Alisher Usmanov, the resumption of this investigation is ruled out
FRANKFURT and MUNICH, Germany, Nov. 20, 2024 (GLOBE NEWSWIRE) -- In response to media inquiries, Alisher Usmanov’s legal representatives at Wannemacher & Partner Rechtsanwälte confirm:
By an Order of 8 November 2024, the Frankfurt am Main General Public Prosecutor’s Office informed about a final waiver of public prosecution in terms of the investigation against Mr. Alisher Usmanov. The investigation has been terminated with his consent pursuant to Article 153a (1) (2) of the German Code of Criminal Procedure following the receipt of a voluntary payment that had been agreed with the General Public Prosecutor’s Office, and which is directed, in part, towards the support of charitable activities.
The termination of the investigation under this legal provision does not constitute admission of guilt. In addition, the payment does not represent a fine or other type of punishment, and the presumption of innocence remains. Pursuant to Article 153a (1) (5) of the German Code of Criminal Procedure, the resumption of investigation against Mr. Usmanov on these suspicions is ruled out.
Attorneys
Uwe Lehmbruck
Markus Gotzens
*Source Wannemacher & Partner Rechtsanwälte
Contact:
muenchen@wannemacher-partner.de
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S13.6.2026 18:45:00 CEST | Press release
Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
King Faisal Specialist Hospital & Research Centre13.6.2026 15:57:00 CEST | Press release
KFSH Showcases Trusted AI as the Foundation for Scalable Healthcare Transformation at HLTH Europe 2026
Chery Group13.6.2026 11:39:45 CEST | Press release
FREELANDER 8 Makes First Public Appearance Ahead of Official Abu Dhabi Launch
Hotel Belles Rives13.6.2026 00:11:17 CEST | Press release
Julian Barnes Named Laureate of the 2026 Fitzgerald Prize
Sanofi Winthrop Industrie13.6.2026 00:09:43 CEST | Press release
Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom